RNU6-964P

Across TCGA pan-cancer cohorts, RNU6-964P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNU6-964P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU6-964P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-964P is over-expressed in tumor.

BRCA, CHOL, and READ are the cancer types where RNU6-964P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-964P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.222	.012	4	view →
CHOL	All	All	+1.012	<.001	2	view →
READ	All	III,IV	+0.960	<.001	2	view →
PRAD	All	All	+0.216	.018	2	view →
STAD	Male	All	+0.332	.037	1	view →
LIHC	All	All	+0.054	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RNU6-964P–BRCA

Open the BRCA breakdown →